22nd Century Group Inc

NASDAQ:XXII  
2.46
-0.05 (-1.99%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)393.99M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.07 Million
Adjusted EPS-$0.06
See more estimates
10-Day MA$2.66
50-Day MA$2.70
200-Day MA$3.47
See more pivots

22nd Century Group Inc Stock, NASDAQ:XXII

500 Seneca Street, Suite 507, Buffalo, New York 14204
United States of America
Phone: +1.716.270.1523
Number of Employees: 67

Description

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.